I rely on a diverse array of reliable sources for my research, including peer-reviewed studies, medical journals, and databases like PubMed and BMJ. I choose Google Scholar and other sites as a means to finding other sources of information knowing that information needs to be quantified. As far as the CDC and the FDA websites are concerned, my skepticism is that they will not post their own shortcomings on their own websites. Instead, we need to look towards more reputable and non-biased news or research sources that are not connected financially to these government agencies. For example, the American Medical Association has recognized the public’s lack of trust in the CDC, highlighting the need for greater transparency (American Medical Association, 2020) where it will carry more weight if the CDC actually acknowledges what many have already felt was a lack of transparency of information during the recent COVID-19 pandemic. Similarly, I believe that The Washington Post is considered a legitimate and reliable news source. The Post reported that the CDC experienced “technical blunders and botched messaging” that were brought to public attention by friends, supporters, and even some professionals within the CDC’s own Atlanta headquarters (Sun & Achenbach, 2020).

Evidence-based Medicine? 

Dr. Jon Jureidini, a child psychiatrist in Australia and a member of the Critical and Ethical Mental Health (CEMH) research group, authored ‘The Illusion of Evidence-based Medicine’ (2022). The CEMH conducts critical appraisal, meta-research, teaching, and advocacy, with the goal of promoting safer, more effective, and more ethical research and practice in the field of mental health (Staff Directory | Dr Jon Jureidini, n.d.).

Dr. Jon Jureidini reports that medicine is mostly dominated by a few very large and competing pharmaceutical companies, that are quite aligned in their methods to expand their profits. He reports on the issues of evidence-based medicine being compromised by the commercialization of academia, failed regulation, and other corporate influences. This doctor sees the scientific progress being abused by the medical industry and its relationship with academic researchers, as they often do not share raw data, suppress negative trial results, and fail to report adverse events. Because of this, there is a greater potential for patient death, due to commercial interests’ influence upon regulators, research agenda, and universities. He strongly suggests that reforms need to be made in all of these areas, in order to bring trust and legitimacy back to evidence-based medicine. Jureidini calls for a separation of regulators from drug company funding, due to regulators often accepting funding and industry-funded trials to approve drugs that a particular company is trying to market (Jureidini, 2022).

Why Drug Marketing Rules America 

Lydia Green, a pharmacist, and former pharmaceutical advertising copywriter speaks about her goals of decreasing the sway of influence of pharmaceutical marketing and misinformation on the American healthcare industry. America contributes only 5% to the population of the world yet spends 1/3 of the world’s $1.4 trillion pharmaceutical healthcare marketplace. In spite of spending the most, the US often ranks low on the overall health of its population. Medicine often prioritizes profit over patient well-being. These pharmaceutical companies are businesses that at their root, just like all businesses, operate to make a profit. Again, it is all about the money. When healthcare and its relative components of pharmaceuticals, doctors, and the profits that both can gain from promoting their products, despite actual need – this whole system is severely corrupt and broken and in need of drastic reform. Green proposes a need for a 3rd party agency to help return trust, regarding the pharmaceutical industry. This alliance would be made up of communicators, marketers, former pharma-ad writers, medical and pharmacy schools, and doctors who have no influence from companies with profits as their sole motivation. However, Green suggests that such an organization could be funded through payments, but once again from fees attached to monies that pharmaceutical and medical device companies make to doctors (TEDx Talks, 2020b).

DTC Pharmaceuticals

In 2015, the US pharmaceutical industry spent $5.4 billion on direct-to-consumer (DTC) advertisements. The U.S. is one of only 2 countries that legally allow DTC for drug companies. New Zealand is the other. Not coincidently, Americans pay more for drugs and medical devices than any other country in the world (Drugwatch, 2022).

Michelle Llamas, a Board Certified Patient Advocate (BCPA) has a long list of experience, but what makes her credible to this article is her almost a decade of medical writing and research experience. She is a trusted source for information on high-risk prescriptions, health conditions, drugs, and medical devices (Drugwatch, 2023).

Drug companies often invest billions of dollars in their attempts to promote off-labeling of their drugs and/or devices that are not approved for other uses by the Food and Drug Administration (FDA). Companies try to convince doctors to prescribe their brand-name drugs or devices, for uses other than their original approval. Additionally, drug companies sometimes create clinical trials focused on swaying doctors and educational courses to highlight expensive drugs for non-FDA-approved uses, despite having no scientific evidence of efficacy or safety. Drug and device companies spent in 2015, about $4 billion on television ads, and about $1.5 billion in magazine advertising. Radio, theaters, newspapers, billboards, and some other types of marketing took up an additional few million dollars. It paid off for these companies to advertise, as every dollar spent on advertising generated increased sales of prescription drugs by $4.40. Big pharmaceutical companies are willing to gamble on being fined for a few hundred million dollars, despite their product being found to cause adverse effects if they know that they can market a product that may generate billions of dollars in profit (Drugwatch, 2022). From a business perspective, this is a good business model. From an ethical perspective, this is downright criminal and inhumane.

Another area of concern is that the CDC often receives funding from the exact same pharmaceutical companies that it is tasked with regulating. The ASH Clinical News, a magazine for the American Society of Hematology, reported that the CDC Foundation received $79.6 million from companies like Pfizer, Biogen, and Merck between 2014 and 2018. The CDC responded that the agency doesn’t accept commercial support, but its own media office has stated that “the CDC claims its public-private partnerships are synergistic and beneficial” (CDC Pressed to Acknowledge Industry Funding, 2021).

FDA Allows Toxic Ingredients in the US, But Other Countries Ban Them

“The FDA has once again failed the public by ignoring the harmful effects of phthalates on our health,” said Kristina Sinclair, associate attorney at the Center for Food Safety. “The agency’s refusal to pay attention to scientific evidence will have detrimental health effects for years to come” (Earthjustice: FDA Approves Use of Toxic Chemicals Leaping Into Food and Beverages, (2023).

“Despite its nearly $7 billion annual operating budget, the U.S. Food and Drug Administration (FDA) isn’t analyzing every shampoo or supplement on sale at your local drugstore. In fact, the FDA does not approve most cosmetics before they hit shelves—let alone assess how they’ll affect human health after years of regular use. This information vacuum has given rise to a network of nonprofits, consumer-protection groups, and independent scientists dedicated to informing the public about potential hazards lurking in their products.” (Ducharme, 2024).

Red Dye No. 3, brominated vegetable oil, potassium bromate, propylparaben, titanium dioxide, and other chemicals are banned in other countries, where the FDA allows these to be added to food products in the US (Worthington, 2024).

Don’t Burn Bridges With Your Future Employer

Lastly, I find it disturbing that there is a merry-go-round of employment where high-level pharmaceutical executives and directors of the FDA go to work for one another, whereas in other types of business, these interactions would be considered conflicts of interest. For this issue, I found that NPR, National Public Radio (considered a reputable news source) reported that from 2001 through 2010 about 27% of its FDA employees who approved cancer and hematology drugs, went on to work for the pharmaceutical companies. The potential conflict of interest here is that FDA employees may have a career goal of later working in the public sector at pharmaceutical companies that they are in charge of regulating. Will these FDA regulators give pharma companies the benefit of the doubt for their products or be more critical of them by using poor comparisons in drug studies?  The article did bring up the idea that having former FDA officials on the pharmaceutical industry payroll can offer some benefits to the general public. Former FDA employees having knowledge of the drug approval process can help facilitate the processes and relevant research that needs to be completed, and where the most current pathways to approval are followed (Lupkin, 2016). Another more recent peer-reviewed article from the Stanford Law School addressed this exact issue in further detail (Karas, 2023). We all know these issues are wrong and continue to go along with the societal cognitive dissonance, hoping that it will all work out and the general population will be fine.

Be well, become healthier, and be wise. Do your research.

References:

American Medical Association & American Medical Association. (2020, September 15). Words and actions that erode trust in the CDC hurt us all. American Medical Association. https://www.ama-assn.org/about/leadership/words-and-actions-erode-trust-cdc-hurt-us-all

Sun, L. H., & Achenbach, J. (2020, September 28). CDC’s credibility is eroded by internal blunders and external attacks as coronavirus vaccine campaigns loom. Washington Post. https://link.gale.com/apps/doc/A636718930/HWRC?u=vol_vsc&sid=bookmark-HWRC&xid=505e0540

CDC pressed to acknowledge industry funding. (2021, December 30). ASH Clinical News | American Society of Hematology. https://ashpublications.org/ashclinicalnews/news/4797/CDC-Pressed-to-Acknowledge-Industry-Funding

Lupkin, S. (2016, September 28). A look at how the revolving door spins from FDA to industry. NPR. https://www.npr.org/sections/health-shots/2016/09/28/495694559/a-look-at-how-the-revolving-door-spins-from-fda-to-industry

Karas, L. (2023). Fda’s Revolving Door: Reckoning and Reform. Stanford Law & Policy Review, 34(1), 1.

Drugwatch. (2022, November 21). Selling Side Effects – Big Pharma’s Marketing Machine. Drugwatch.com. https://www.drugwatch.com/featured/big-pharma-marketing/

Drugwatch. (2023, February 23). Michelle Llamas – Drugwatch Senior Writer. Drugwatch.com. https://www.drugwatch.com/authors/mllamas/

Jureidini, J. (2022, March 16). The illusion of evidence based medicine. The BMJ. https://www.bmj.com/content/376/bmj.o702

Staff Directory | Dr Jon Jureidini. (n.d.). https://www.adelaide.edu.au/directory/jon.jureidini

TEDx Talks. (2020b, November 23). Why Drug Marketing Rules American Healthcare and What We Can Do About it | Lydia Green | TEDxMcphs. YouTube. https://www.youtube.com/watch?v=Jh7rQbknPyE

Earthjustice: FDA Approves Use of Toxic Chemicals Leaping Into Food and Beverages. (2023, July 23). Targeted News Service, NA. https://link.gale.com/apps/doc/A758209943/STND?u=vol_vsc&sid=ebsco&xid=6ec0ba16

Ducharme, J. (2024). Scientists Are Finding Out Just How Toxic Your Stuff Is. Time.Com, N.PAG

Worthington, L. (2024, April 3). These common U.S. snack ingredients are banned or restricted abroad. Science. https://www.nationalgeographic.com/science/article/additives-artificial-flavors-us-snacks-banned

I teach and offer lectures about holistic health, stress management, qigong, tai chi, baguazhang, meditation, phytotherapy (herbs), music for healing, self-massage, and Daoyin (yoga).

Please contact me if you, your business, organization, or group, might be interested in hosting me to speak on a wide spectrum of topics relative to better health, wellness, and fitness.

I look forward to further sharing more of my message by partnering with hospitals, wellness centers, VA centers, schools on all levels, businesses and individuals that see the value in building a stronger nation through building a healthier population. I also have hundreds of FREE education video classes, lectures and seminars available on my YouTube channel at:

https://www.youtube.com/c/MindandBodyExercises

www.MindAndBodyExercises.com

www.Amazon.com/author/jimmoltzan

Mind and Body Exercises on Google: https://posts.gle/aD47Qo

Jim Moltzan

407-234-0119